Clinical experiment designed to assess clinical efficacy targeting N/A in pediatric patients. Primary outcome: antidepressant efficacy and safety
Clinical assessment of ketamine and esketamine safety and efficacy in pediatric patients with treatment-resistant depression. This specialized population study examined the use of NMDA receptor antagonists in children and adolescents who had not responded to standard antidepressant treatments. The research focused on age-appropriate dosing, developmental considerations, and the unique risk-benefit profile in younger patients, including assessment of potential impacts on developing neural systems and long-term safety concerns specific to pediatric populations.
Pediatric-adapted ketamine/esketamine administration with specialized monitoring protocols
Effective antidepressant response with acceptable pediatric safety profile
Demonstration of efficacy with minimal adverse effects appropriate for pediatric use
No related hypotheses
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.